The CB1 receptor antagonist SR141716A heightens the development of tolerance to alcohol and modulates symptoms of dependence.

被引：0
|
作者：
Nowak, KL [1 ]
Yaragudri, V [1 ]
Hungund, BL [1 ]
机构：
[1] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2004年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：142A / 142A
页数：1
相关论文
共 50 条
  • [21] The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat
    Chapman, V
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (08) : 1765 - 1767
  • [22] The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by Δ9-tetrahydrocannabinol or anandamide
    Mallet, PE
    Beninger, RJ
    PSYCHOPHARMACOLOGY, 1998, 140 (01) : 11 - 19
  • [23] The cannabanoid 1 (CB1) receptor antagonist SR141716A reduces vasodilation to hypotension in rat middle cerebral arteries (MCA)
    DeWitt, DS
    Mathew, B
    Bukoski, RD
    Prough, DS
    ANESTHESIOLOGY, 1999, 91 (3A) : U328 - U328
  • [24] Rapid tolerance to the intestinal prokinetic effect of cannabinoid CB1 receptor antagonist, SR 141716 (Rimonabant)
    Carai, MAM
    Colombo, G
    Gessa, GL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) : 221 - 224
  • [25] Functional inverse agonism of SR141716A on rat and human central cannabinoid CB1 receptor
    Valdizan, E. M.
    Mato, S.
    Pazos, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 72 - 72
  • [26] A comparison of the effects of the CB1 receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour
    Thornton-Jones, Zoe D.
    Kennett, Guy A.
    Vickers, Steven P.
    Clifton, Peter G.
    PSYCHOPHARMACOLOGY, 2007, 193 (01) : 1 - 9
  • [27] The CB1 Receptor Antagonist SR141716A Reverses Adult Male Mice Overweight and Metabolic Alterations Induced by Early Stress
    Valenzuela, Carina A.
    Castillo, Valeska A.
    Aguirre, Carolina A.
    Ronco, Ana M.
    Llanos, Miguel N.
    OBESITY, 2011, 19 (01) : 29 - 35
  • [28] A comparison of the effects of the CB1 receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour
    Zoë D. Thornton-Jones
    Guy A. Kennett
    Steven P. Vickers
    Peter G. Clifton
    Psychopharmacology, 2007, 193 : 1 - 9
  • [29] The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions
    Tzavara, ET
    Davis, RJ
    Perry, KW
    Li, X
    Salhoff, C
    Bymaster, FP
    Witkin, JM
    Nomikos, GG
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (04) : 544 - 553
  • [30] Blockade by the cannabinoid CB1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats
    Serra, S
    Brunetti, G
    Pani, M
    Vacca, G
    Carai, MAM
    Gessa, GL
    Colombo, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 443 (1-3) : 95 - 97
12345